Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.
| Status: | Archived |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
| End Date: | February 2013 |
(OSKIRA-2): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With an Inadequate Response to DMARDs
The purpose of the study is to evaluate the effectiveness of two dosing regimens of
fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking
disease modifying anti-rheumatic drug (DMARD) but not responding. The study will last for 1
year.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials